Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 106 AL 120

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)

Mishra P, Kumar A, Panda G.

Bioorg Med Chem. 2019 Mar 15;27(6):895-930. doi: 10.1016/j.bmc.2019.01.025. Epub 2019 Jan 25.

A core transcriptional signature of human microglia: Derivation and utility in describing region-dependent alterations associated with Alzheimer's disease

Patir A, Shih B, McColl BW, Freeman TC.

Glia. 2019 Jul;67(7):1240-1253. doi: 10.1002/glia.23572. Epub 2019 Feb 13.

The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation

Castellani RJ, Plascencia-Villa G, Perry G.

Lab Invest. 2019 Jul;99(7):958-970. doi: 10.1038/s41374-019-0231-z. Epub 2019 Feb 13.

Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis

Li M, Luo Z, Yu S, Tang Z.

Medicine (Baltimore). 2019 Feb;98(7):e14422. doi: 10.1097/MD.0000000000014422.

γ-Secretase and its modulators: Twenty years and beyond

Xia W.

Neurosci Lett. 2019 May 14;701:162-169. doi: 10.1016/j.neulet.2019.02.011. Epub 2019 Feb 11.

Apathy in Dementia: Time to StandUp

Starkstein S, Hayhow B.

Am J Geriatr Psychiatry. 2019 Apr;27(4):406-407. doi: 10.1016/j.jagp.2018.12.035. Epub 2019 Jan 9.

Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease

Santos JRF, Bauer C, Schuchhardt J, Wedekind D, Waniek K, Lachmann I, Wiltfang J, Vogelgsang J.

J Neural Transm (Vienna). 2019 Mar;126(3):339-348. doi: 10.1007/s00702-019-01982-5. Epub 2019 Feb 14.

Delusions in Alzheimer Disease: What Researchers Should Not Forget

Prasad KM.

Am J Geriatr Psychiatry. 2019 May;27(5):499-501. doi: 10.1016/j.jagp.2018.12.034. Epub 2019 Jan 9.

The role of mitochondrial defects and oxidative stress in Alzheimer's disease

Islam BU, Jabir NR, Tabrez S.

J Drug Target. 2019 Nov;27(9):932-942. doi: 10.1080/1061186X.2019.1584808. Epub 2019 Mar 26.

Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?

Franco R, Martínez-Pinilla E, Navarro G.

Expert Opin Drug Discov. 2019 Apr;14(4):327-330. doi: 10.1080/17460441.2019.1581169. Epub 2019 Feb 18.

On the Etiopathogenesis and Pathophysiology of Alzheimer's Disease: A Comprehensive Theoretical Review

Tobore TO.

J Alzheimers Dis. 2019;68(2):417-437. doi: 10.3233/JAD-181052.

The Role of Apolipoprotein E Isoforms in Alzheimer's Disease

Roda AR, Montoliu-Gaya L, Villegas S.

J Alzheimers Dis. 2019;68(2):459-471. doi: 10.3233/JAD-180740.

Potential role of miRNA-140 in Alzheimer's disease

Akhter R, Bekris LM.

Aging (Albany NY). 2019 Feb 19;11(4):1087-1088. doi: 10.18632/aging.101827.

Shared mechanisms: osteoporosis and Alzheimer's disease?

Dengler-Crish CM, Elefteriou F.

Aging (Albany NY). 2019 Feb 19;11(5):1317-1318. doi: 10.18632/aging.101828.

The Effectiveness of Vitamin E Treatment in Alzheimer's Disease

Lloret A, Esteve D, Monllor P, Cervera-Ferri A, Lloret A.

Int J Mol Sci. 2019 Feb 18;20(4):879. doi: 10.3390/ijms20040879.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias